Crossmark

Oral calcium supplementation versus placebo in mitigating citrate reactions during apheresis: an open-label randomized control trial

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.06.010

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Abe, Masaya https://orcid.org/0000-0003-2937-739X
Fujii, Keiko https://orcid.org/0009-0005-7614-2448
Fujii, Nobuharu

Mitsuhashi, Toshiharu https://orcid.org/0000-0001-9940-0570
Fukumi, Takuya

Sumii, Yuichi

Kimura, Maiko

Urata, Tomohiro

Kondo, Takumi https://orcid.org/0000-0002-6395-7913
Otsuka, Fumio https://orcid.org/0000-0001-7014-9095
Maeda, Yoshinobu
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-09-11
More Information

This article is maintained by: Elsevier

Article Title: Oral calcium supplementation versus placebo in mitigating citrate reactions during apheresis: an open-label randomized control trial

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.06.010

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.